New Immuno-Oncology Targets and Resistance Mechanisms
Science in Seattle,
Immune checkpoint inhibition (ICI) has revolutionized the field of non-small cell lung cancer (NSCLC); currently, most patients…
Immune checkpoint inhibition (ICI) has revolutionized the field of non-small cell lung cancer (NSCLC); currently, most patients…
With Nadia Howlader, PhD, of the NCI's Division of Cancer Control
Ogni mese per i lettori di Oncoinfo una selezione dalla letteratura scientifica internazionale sul tema. The post Medicina di…
Deaths from the most common lung cancer, non-small cell lung cancer, declined sharply after 2013, faster than the drop in new…